Recordati Rare Diseases anuncia la publicaci贸n en el

Recordati Rare Diseases anuncia la publicaci贸n en el Journal of Clinical Endocrinology & Metabolism del estudio de fase III LINC 4 que confirma la eficacia y seguridad de Isturisa庐 (osilodrostat) en pacientes con enfermedad de Cushing - Iberonews

Recordati Rare Diseases anuncia la publicaci贸n en el Journal of Clinical Endocrinology & Metabolism del estudio de fase III LINC 4 que confirma la eficacia y seguridad de Isturisa庐 (osilodrostat) en pacientes con enfermedad de Cushing - Iberonews
iberonews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iberonews.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

France , Germany , Mexico , Australia , Japan , Milan , Lombardia , Italy , United States , Austria , Puteaux , France General , Canada , Russia , Greece , Turkey , Ukraine , Italian , America , American , Alberto Pedroncelli , Tabarina Cushing , Italian Stock Exchange Reuters , Endocrine Society , Clinical Development Medical Affairs , European Commission , Recordati Rare Diseases , Clinical Endocrinology , Lancet Diabetes , Clinical Development , Medical Affairs Lead , Global Endocrinology , Rare Diseases , Clin Endocrinol Metab , Pract Res Clin Endocrinol Metab , Diabetes Endocrinol , Italian Stock Exchange , North Africa , South American ,